Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
GHK-CU A copper-binding peptide studied in laboratory research related to extracellular matrix protein synthesis modeling, fibroblast activity studies, and matrix metalloproteinase pathway research
Therapeutic angiogenesis using HGF plasmid
A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity
By summarizing the results of the SURMOUNT and SURPASS clinical trials, we evaluate the efficacy and safety of tirzepatide in reducing blood glucose and weight
The absence of dietary carbohydrates when you administer the peptide allows it to preferentially target stored adipose tissue
This accelerates in aqueous solution and at higher pH
US$ 29.36
US$ 21.97
US$ 27.96
.webp)
US$ 20.32
